140 related articles for article (PubMed ID: 12802835)
1. White coat hypertension in treated hypertensives: a three year follow-up study.
MacDonald MB; Laing GP; Wilson MP; Wilson TW
Can J Cardiovasc Nurs; 2003; 13(2):24-9. PubMed ID: 12802835
[TBL] [Abstract][Full Text] [Related]
2. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Sacchi N; Guerrieri M; Comparato E; Porcellati C
Blood Press Monit; 1996 Jun; 1(3):217-222. PubMed ID: 10226230
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
4. Frequent nurse visits decrease white coat effect in stage III hypertension.
Guerra-Riccio GM; Artigas Giorgi DM; Consolin-Colombo FM; Barreto-Filho JA; Lopes HF; Fleury Camargo AL; Moacyr Krieger E
Am J Hypertens; 2004 Jun; 17(6):523-8. PubMed ID: 15177526
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring.
Abir-Khalil S; Zaîmi S; Tazi MA; Bendahmane S; Bensaoud O; Benomar M
East Mediterr Health J; 2009; 15(2):400-7. PubMed ID: 19554987
[TBL] [Abstract][Full Text] [Related]
6. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
[TBL] [Abstract][Full Text] [Related]
7. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
[TBL] [Abstract][Full Text] [Related]
9. [The white coat effect in primary care. Analysis of patients with newly diagnosed arterial hypertension].
Mayoral E; Lapetra J; Santos JM; López A; Ruiz J; Cayuela A
Med Clin (Barc); 1997 Apr; 108(13):485-9. PubMed ID: 9235424
[TBL] [Abstract][Full Text] [Related]
10. [Is white-coat hypertension a disease?].
Bloch A
Praxis (Bern 1994); 1997 Jan; 86(1-2):6-8. PubMed ID: 9045279
[TBL] [Abstract][Full Text] [Related]
11. Isolated office hypertension: a 3-year follow-up study.
Grandi AM; Solbiati F; Laurita E; Cassinerio E; Marchesi C; Piperno F; Maresca A; Guasti L; Venco A
Blood Press; 2005; 14(5):298-305. PubMed ID: 16257876
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory blood pressure monitoring in the elderly hypertensive patient.
Torriani S; Waeber B; Petrillo A; Di Stefano R; Mooser V; Scherrer U; Nussberger J; Hofstetter JR; Brunner HR
J Hypertens Suppl; 1988 Nov; 6(1):S25-7. PubMed ID: 3216238
[TBL] [Abstract][Full Text] [Related]
13. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
[TBL] [Abstract][Full Text] [Related]
14. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
15. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between body-mass index and white-coat hypertension among referred patients.
Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension.
Yildiz A; Gür M; Yilmaz R; Demirbağ R; Celik H; Aslan M; Koçyiğit A
Turk Kardiyol Dern Ars; 2008 Jun; 36(4):231-8. PubMed ID: 18765966
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the white-coat effect at multiple visits before and during treatment.
Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
[TBL] [Abstract][Full Text] [Related]
19. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
[TBL] [Abstract][Full Text] [Related]
20. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
